Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...
Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant ...
Shares are up 7% in trading today, after Geron announced a strategic restructuring to "position the company for long-term ...
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...
A new study has revealed that neural inhibition and balanced neural activity in a specific area of the brain is required for ...
Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) ...
A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.
ABSTRACT: Aromatase inhibitors (AIs) have been suggested as adjuncts to delay skeletal maturation and extend growth potential in boys with idiopathic short stature (ISS), but evidence in Asian ...
Researchers identify neurotoxic protein complex and a pharmacological inhibitor that opens new perspectives for developing effective therapies A research group led by neurobiologist Prof. Dr. Hilmar B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback